MSD
Pembrolizumab/Lenvatinib
Biodrugs/ Drugs
Cancer
Pembrolizumab and lenvatinib in Combination with Transarterial Chemoembolization (TACE) Versus TACE in Participants with Incurable/Non-metastatic Hepatocellular Carcinoma
3Phase III in Spain,
2Phase II,
1Phase I